María Carmen
Rivas Vázquez
Investigadora CSIC-USC
Icahn School of Medicine at Mount Sinai
Nueva York, Estados UnidosPublicacións en colaboración con investigadores/as de Icahn School of Medicine at Mount Sinai (11)
2024
-
SUMOylation modulates eIF5A activities in both yeast and pancreatic ductal adenocarcinoma cells
Cellular and Molecular Biology Letters, Vol. 29, Núm. 1
2022
-
eIF5A is activated by virus infection or dsRNA and facilitates virus replication through modulation of interferon production
Frontiers in Cellular and Infection Microbiology, Vol. 12
2021
2014
-
A unified nomenclature and amino acid numbering for human PTEN
Science Signaling, Vol. 7, Núm. 332
2010
-
Dual role of p53 in innate antiviral immunity
Viruses, Vol. 2, Núm. 1, pp. 298-313
2009
-
Kaposi's sarcoma-associated herpesvirus protein LANA2 disrupts PML oncogenic domains and inhibits PML-mediated transcriptional repression of the survivin gene
Journal of Virology, Vol. 83, Núm. 17, pp. 8849-8858
2008
-
Induction of paclitaxel resistance by the Kaposi's sarcoma-associated herpesvirus latent protein LANA2
Journal of Virology, Vol. 82, Núm. 3, pp. 1518-1525
-
The sequential activation of the yeast HOG and SLT2 pathways is required for cell survival to cell wall stress
Molecular Biology of the Cell, Vol. 19, Núm. 3, pp. 1113-1124
2007
-
Control of virus infection by tumour suppressors
Carcinogenesis, Vol. 28, Núm. 6, pp. 1140-1144
-
Novel and unexpected role for the tumor suppressor ARF in viral infection surveillance
Future Virology, Vol. 2, Núm. 6, pp. 625-629
2006
-
Antiviral action of the tumor suppressor ARF
EMBO Journal, Vol. 25, Núm. 18, pp. 4284-4292